查看購物車
  • Simplified Chinese
  • English
  • Japanese
封面
市場調查報告書
商品編碼
1861937

超音波切片檢查設備市場按產品類型、產品供應、最終用戶、應用和適應症分類－2025-2032年全球預測

Endobronchial Ultrasound Biopsy Devices Market by Product Type, Product Offering, End User, Application, Indication - Global Forecast 2025-2032
出版日期: | 出版商: 360iResearch | 英文 196 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

預計到 2032 年，支氣管內超音波切片檢查設備市場規模將達到 11.07 億美元，複合年成長率為 5.95%。

關鍵市場統計數據
基準年 2024 6.9715億美元
預計年份：2025年 7.3874億美元
預測年份 2032 11.07億美元
複合年成長率 (%) 5.95%

全面概述超音波切片檢查技術的臨床價值、技術基礎和影響其應用的策略因素

超音波切片檢查裝置已成為現代呼吸系統疾病診療中的關鍵診斷手段，它將影像學檢查和組織取樣整合於單一操作流程中。這些裝置結合了支氣管鏡檢查和超音波影像，能夠更精準地定位和取樣縱隔及周圍肺部病變。臨床醫生正在採用這項技術，以提高診斷準確率，減少重複檢查，並支持腫瘤科、感染疾病和間質性肺病科等多學科團隊的決策。

技術已從基礎超音波探頭發展到如今的整合系統，這些系統注重人體工學、更高的成像精度以及可降低交叉感染風險的一次性耗材。隨著手術流程的不斷改進，支付方和醫院系統不僅日益重視設備效能，還關注吞吐量、庫存複雜性和生命週期成本。因此，採購部門和臨床團隊在購買或更新超音波平台時，必須考慮設備的互通性、訓練要求以及上市後監測數據。

本文概述了臨床價值提案、成像和切片檢查能力的融合以及醫療機構在評估對超音波切片檢查技術的投資時應考慮的戰略因素，為後續分析技術變革、監管影響和供應鏈因素如何共同影響技術的採用和臨床整合奠定了基礎。

新興技術進步和臨床工作流程的變革正在重新定義超音波切片檢查的準確性、安全性和操作整合性。

近年來，支氣管內超音波切片檢查設備領域發生了變革性變化，這反映了影像解析度的提高、一次性耗材策略的推廣以及複雜手術向門診的轉移。探頭設計和訊號處理的改進使得病灶和淋巴結的顯像更加清晰，從而能夠更精準地進行經支氣管針吸活體組織切片，並減少非診斷性檢體的獲取。同時，製造商優先開發一次性針頭套裝和保護鞘套，以簡化消毒流程並降低交叉感染的風險，這在後疫情時代的臨床管治中尤其重要。

此外，整合影像工作站和內視鏡系統的進步提高了資料收集能力，並促進了與電子健康記錄和手術記錄的整合。這些進步透過提供高解析度影像和切片檢查元資料，為多學科腫瘤委員會提供支持，從而指導長期治療決策。此外，技術在門診手術中心和專科診所的普及也反映了手術報銷結構的變化以及在控制成本的同時提高患者吞吐量的努力。

基於人工智慧的影像和手術指導將進一步變革臨床工作流程，提高病灶標靶化的準確性並規範採樣策略。因此，相關人員需要調整培訓課程、完善認證架構並重新評估資本規劃，以適應以精準性、安全性和營運效率為優先的新情勢。

美國關稅調整導致供應鏈韌性和籌資策略重塑，推動了設備生態系統內供應商多元化和區域化生產。

2025年美國關稅調整的累積影響正波及全球醫療設備供應鏈，迫使製造商和醫療服務提供者重新評估其超音波切片檢查設備的籌資策略。關稅導致進口零件成本上升，推高了製造成本，尤其是那些依賴跨境生產關鍵子組件和專用超音波換能器的公司。為因應這項挑戰，各公司正在加速供應商多元化，盡可能轉向區域供應商，並在某些情況下重新調整本地製造投資的優先級，以降低未來政策變化帶來的風險。

在臨床採購方面，對關稅風險的高度重視促使醫院系統和集團採購組織協商長期供應協議，並在採購決策中強調整體擁有成本。這些談判越來越重視耗材供應和售後支持，將其視為設備價值的關鍵因素。同時，製造商也在尋求透過流程改善、精益生產實踐以及減少對受關稅影響的原料依賴的設計選擇來分擔部分成本負擔。

最後，監管和合約團隊越來越重視取證要求。對於相關人員，關稅情勢凸顯了情境規劃、多元化供應商網路以及包含成本轉嫁條款的合約的重要性，以確保能夠穩定地獲得超音波切片檢查設備及相關耗材。

詳細的細分觀點揭示了產品類型、功能、最終用戶、應用和臨床適應症如何獨特地影響設備的選擇和採用。

市場區隔分析從產品類型、產品組合、最終用戶、應用和臨床適應症等角度檢驗市場，揭示清晰的性能促進因素和市場推廣路徑。在產品類型方面，可區分使用縱向探針（能夠直接觀察縱膈和肺門淋巴結的針吸切片檢查）和徑向探針（能夠更精準地定位外周病灶並支持輔助診斷策略）的設備。在產品組合方面，影像工作站和內視鏡系統等設備投資構成資本規劃和整合成本的基礎，而針組和保護鞘套等耗材則影響經常性支出和手術量。

終端用戶環境進一步影響了採用趨勢：門診手術中心優先考慮緊湊高效的系統和精簡的耗材，以支持高通量門診手術；醫院重視先進的成像功能、廣泛的設備互通性和全面的服務協議；專科診所則尋求兼顧診斷性能、空間和人員限制的經濟高效的配置。應用範圍涵蓋縱隔分期（需要高精度和可重複性）、周邊病變診斷（病變可及性和圖像解析度至關重要）以及經支氣管針吸切片檢查（結合成像和組織採集，重點關注針頭設計和採樣效率）。

最後，從癌症診斷到感染疾病評估再到類肉瘤病病評估等臨床適應症，都會影響設備的選擇和通訊協定，因為組織合格、樣本處理和下游分子檢測要求在這些診斷途徑之間差異很大。

區域採用模式和商業性需求將影響部署、培訓和售後市場策略。

區域趨勢對美洲、歐洲、中東和非洲以及亞太地區的採用模式、監管預期和商業策略產生了顯著影響。在美洲，高技能的三級醫療中心和強大的介入肺科計畫集中分佈，推動了整合影像工作站和先進內視鏡系統的早期應用；同時，支付方也越來越檢驗手術流程的成本效益和治療結果的一致性。向門診手術環境的轉變催生了新的採購重點，這些重點圍繞著移動性、易操作性和耗材生命週期管理。

在歐洲、中東和非洲地區，由於法規環境和醫院資金籌措模式的差異，醫療設備部署呈現以醫院為中心和以專科診所為主導的混合模式。製造商通常會根據各國的醫保報銷體係以及與區域臨床協會的培訓合作關係來制定打入市場策略。在亞太地區，都市區三級醫療中心加速採用醫療設備以及癌症診斷基礎設施投資帶來的裝機量成長尤為顯著。本地生產和區域經銷夥伴在成本控制和服務應對力發揮關鍵作用。

這些地區的通用趨勢包括：重視臨床醫師訓練、重視服務和保障體系，以及耗材管理在維持檢測量上的策略角色。因此，在規劃市場進入或擴張時，決策者應評估每個地區的監管路徑、報銷細則和當地臨床實踐模式。

競爭格局分析突顯了多種策略模式，從整合平台供應商到耗材專家，並揭示了這些模式對採購和臨床應用的影響。

支氣管內超音波切片檢查生態系統中的主要企業展現出多元化的策略策略，涵蓋從平台整合式解決方案到以耗材為中心的經營模式。現有內視鏡製造商專注於系統層面的差異化，將高解析度成像工作站與模組化內視鏡架構相結合，以掌控手術生態系統並推動耗材輔助產品的銷售。這些公司強調長期服務協議、臨床醫生培訓項目以及捆綁式解決方案，以促進醫院整合並簡化採購談判。

同時，針頭系統和保護鞘套的專業製造商正優先研發以採樣可靠性、組織完整性和一次性使用便利性為核心的技術。他們的商業策略以臨床證據為中心，這些證據能夠證明診斷率的提高和再次手術率的降低，並輔以針對介入性肺科醫生和細胞病理學團隊的專項教育舉措。新參與企業和細分領域的創新者則專注於導航輔助設備、切片檢查鉗和人工智慧影像增強技術等配套技術，並尋求與平台公司建立策略合作夥伴關係，以加速臨床應用。

整體而言，競爭格局取決於兩類供應商之間的平衡：一類是能夠確保持續耗材收入的整合平台，另一類是能夠提供臨床效能優勢和具成本效益一次性產品設計的專業供應商。對於買家而言，這種情況使得評估整體合約安排、服務水準協議以及互通性和軟體支援的長期發展藍圖顯得尤為重要。

為製造商和醫療保健提供者提供切實可行、影響深遠的策略行動，以加速臨床應用、增強供應鏈韌性並提升設備的長期價值。

產業領導者若想鞏固市場地位並支持永續的臨床應用，應採取切實可行的策略，使創新與營運實際情況相契合。首先，應優先考慮內視鏡系統與影像工作站之間的端到端整合，以實現無縫的臨床工作流程，並減輕臨床醫生在診療現場的負擔。其次，引入完善的培訓課程和基於模擬的認證，將有助於提高操作熟練度，最大限度地減少切片檢查技術的差異，從而提升檢體品質和臨床醫生的信心。

第二，我們建立具有韌性的供應鏈，透過多元化零件採購，並在條件允許的地區投資製造和組裝能力，降低貿易和關稅風險。第三，我們提供靈活的採購方案，以因應資金限制（例如，影像工作站的訂閱模式結合可預測的耗材價格），並使商業模式與臨床工作流程相符。第四，我們致力於收集上市後證據，以證明我們的設備對診斷率、後續治療決策和病患體驗的影響，從而為醫保報銷談判和醫院藥品目錄的納入提供支持。

最後，透過促進互通性和開放資料架構，並實現與電子健康記錄和跨專業護理平台的整合，這些努力將共同擴大獲得先進的支氣管內超音波切片檢查能力的機會，同時幫助公司和醫療系統應對不斷變化的臨床期望、監管審查和財務壓力。

我們進行了一項嚴謹的混合調查方法，結合專家訪談、臨床文獻回顧和三角資料分析，以檢驗研究結果並減少偏差。

本分析的調查方法結合了嚴謹的一手和二手研究技術，以確保分析的深度和有效性。一手資料收集包括對介入性肺科醫生、生物醫學工程師、採購人員和醫院管理人員進行結構化訪談，以了解他們在設備性能、培訓需求和耗材物流的真實經驗。這些專家的意見為評估臨床工作流程、設備人體工學和手術瓶頸提供了基礎。

二次研究回顧了同行評審的臨床文獻、醫療器材附加檔和監管申報文件、臨床學會指南以及已發布的監管通告，以支持安全性和有效性聲明並描繪技術發展趨勢。數據三角驗證確保研究結果反映了來自多個資訊來源的趨同證據，並在專家意見存在分歧時進行了敏感性分析。細分市場定義和區域分析的建構與臨床實務模式、報銷架構和供應鏈地理相一致。

本調查方法的限制包括監管環境的變化和技術創新的快速發展，這兩者都會影響醫療設備的功能和應用。為解決此問題，研究團隊在解讀新興技術時格外謹慎，並優先考慮現有的同儕審查證據。倫理方面的考慮包括對訪談參與者進行匿名處理，並徵得他們的同意後，方可將他們的個人發現用於匯總分析。

整合策略要點，重點在於突顯技術進步、供應鏈調整和協作臨床策略，以最大限度地提高診斷效果

總之，支氣管內超音波切片檢查設備在診斷準確性、手術安全性和操作效率方面佔據戰略地位。探頭設計、影像工作站和一次性耗材的技術創新正在提高診斷效能，同時也正在重塑門診手術中心、醫院和專科診所的手術操作方式。同時，關稅和不斷變化的報銷政策等外部壓力正迫使製造商和供應商重新思考其採購、定價和商業化模式。

成功推廣應用需要從整體觀點，考慮設備互通性、臨床醫生培訓、耗材生命週期管理以及上市後證據的產生。透過將產品開發與實際臨床工作流程結合，並建立穩健的供應鏈，相關人員可以加快推廣應用，同時控制整體擁有成本並滿足監管要求。最終，整合平台與高性能耗材之間的平衡將決定醫療機構如何制定採購決策，以及臨床醫生如何提供一致、高品質的診斷結果。

目錄

第1章：序言

第2章調查方法

第3章執行摘要

第4章 市場概覽

第5章 市場洞察

  • 擴大使用即時影像引導的線性支氣管內超音波設備以提高淋巴結取樣準確性
  • 開發一次性超音波探頭，以降低支氣管內切片檢查術中的感染風險和消毒成本
  • 針頭設計的進步，包括可變規格和可調節硬度，可改善EBUS切片檢查過程中對氣道病變的進入。
  • 在EBUS檢查過程中，擴大人工智慧和機器學習演算法在淋巴結自動檢測和惡性腫瘤預測的應用。
  • 擴建配備 EBUS 和內視鏡導航支氣管鏡系統的混合手術室，以簡化診斷和治療流程。
  • 醫療設備製造商與軟體公司合作開發雲端基礎的EBUS資料管理和遠距教學平台
  • 為安全取得更大組織樣本以診斷間質性肺疾病，對微創EBUS引導下切片檢查技術的需求日益成長。

第6章：美國關稅的累積影響，2025年

第7章：人工智慧的累積影響，2025年

8.超音波切片檢查設備市場（依產品類型分類）

  • 線性探針
  • 徑向探針

9.超音波切片檢查設備市場（依產品類型分類）

  • 消耗品
    • 針具套裝
    • 保護鞘套
  • 裝置
    • 影像工作站
    • 內視鏡系統

第10章超音波切片檢查設備市場（依最終用戶分類）

  • 門診手術中心
  • 醫院
  • 專科診所

第11章超音波切片檢查設備市場（依應用領域分類）

  • 縱膈分期
  • 周邊病變診斷
  • 經支氣管針吸切片檢查

第12章超音波切片檢查設備市場（依適應症分類）

  • 癌症診斷
  • 感染疾病
  • 類肉瘤病

第13章 各地區超音波切片檢查設備市場

  • 美洲
    • 北美洲
    • 拉丁美洲
  • 歐洲、中東和非洲
    • 歐洲
    • 中東
    • 非洲
  • 亞太地區

第14章超音波切片檢查設備市場（依組別分類）

  • ASEAN
  • GCC
  • EU
  • BRICS
  • G7
  • NATO

第15章 各國超音波切片檢查設備市場

  • 美國
  • 加拿大
  • 墨西哥
  • 巴西
  • 英國
  • 德國
  • 法國
  • 俄羅斯
  • 義大利
  • 西班牙
  • 中國
  • 印度
  • 日本
  • 澳洲
  • 韓國

第16章 競爭格局

  • 2024年市佔率分析
  • FPNV定位矩陣，2024
  • 競爭分析
    • Olympus Corporation
    • Fujifilm Holdings Corporation
    • HOYA Corporation
    • Boston Scientific Corporation
    • Medtronic plc
    • Karl Storz SE & Co. KG
Product Code: MRR-521BAA36EA81

The Endobronchial Ultrasound Biopsy Devices Market is projected to grow by USD 1,107.00 million at a CAGR of 5.95% by 2032.

KEY MARKET STATISTICS
Base Year [2024] USD 697.15 million
Estimated Year [2025] USD 738.74 million
Forecast Year [2032] USD 1,107.00 million
CAGR (%) 5.95%

Comprehensive overview of clinical value, technological underpinnings, and strategic factors shaping adoption of endobronchial ultrasound biopsy technologies

Endobronchial ultrasound biopsy devices have emerged as a pivotal diagnostic modality within modern pulmonary care, bridging imaging and tissue acquisition in a single procedural workflow. These devices combine bronchoscopic access with real-time ultrasound visualization to improve localization and sampling of mediastinal and peripheral pulmonary lesions. Clinicians deploy the technology to enhance diagnostic yield, reduce repeat procedures, and support multidisciplinary decision-making across oncology, infectious disease, and interstitial lung disease programs.

Technologically, the field has matured from foundational ultrasound probes to integrated systems that emphasize ergonomics, imaging fidelity, and single-use consumables that lower cross-contamination risk. As procedural pathways evolve, payers and hospital systems increasingly evaluate not just device performance but also throughput, inventory complexity, and lifecycle costs. Consequently, procurement and clinical teams must consider device interoperability, training requirements, and post-market surveillance data when adopting or upgrading endobronchial ultrasound platforms.

This introduction frames the clinical value proposition, the convergence of imaging and biopsy capabilities, and the strategic considerations that healthcare organizations should weigh when assessing investment in endobronchial ultrasound biopsy technology. It sets the stage for subsequent analysis of technological shifts, regulatory influences, and supply chain factors that collectively shape adoption and clinical integration.

Emerging technological advancements and clinical workflow metamorphoses that are redefining precision, safety, and operational integration of endobronchial ultrasound biopsy care

Recent transformative shifts in the landscape of endobronchial ultrasound biopsy devices reflect advances in imaging resolution, single-use consumable strategies, and the migration of complex procedures into ambulatory settings. Improved probe design and signal processing have sharpened visualization of lesions and lymph nodes, enabling more precise transbronchial needle aspiration and reducing nondiagnostic samples. Simultaneously, manufacturers have prioritized disposable needle sets and protective sheaths that streamline sterilization workflows and mitigate cross-infection risks, which is particularly salient in post-pandemic clinical governance.

Concurrently, the evolution of integrated imaging workstations and scope systems has enhanced data capture, enabling smoother integration with electronic health records and procedural documentation. These developments support multidisciplinary tumor boards by delivering higher-fidelity images and biopsy metadata for longitudinal care decisions. In addition, the diffusion of the technology into ambulatory surgical centers and specialty clinics reflects procedural reimbursement shifts and efforts to improve patient throughput while containing costs.

Looking forward, artificial intelligence-assisted image interpretation and procedural guidance are likely to further alter clinician workflows, improving lesion targeting and standardizing sampling strategies. As a result, stakeholders must adapt training curricula, refine credentialing frameworks, and reassess capital planning to align with a landscape that increasingly values precision, safety, and operational efficiency.

Supply chain resilience and procurement strategies reshaped by United States tariff adjustments, driving supplier diversification and regional manufacturing responses across device ecosystems

The cumulative impact of United States tariff adjustments in 2025 has reverberated across global medical device supply chains, compelling manufacturers and healthcare providers to reassess sourcing and procurement strategies for endobronchial ultrasound biopsy devices. Tariff-driven increases in component import costs have created upward pressure on manufacturing expenses, particularly for firms that rely on cross-border production of critical subassemblies and specialized ultrasound transducers. Firms responded by accelerating supplier diversification, shifting to regional vendors where feasible, and, in some cases, reprioritizing local manufacturing investments to mitigate future policy volatility.

On the clinical procurement side, acute awareness of tariff risk has prompted hospital systems and group purchasing organizations to negotiate longer-term supply contracts and to emphasize total cost of ownership in purchasing decisions. These negotiations increasingly consider consumable availability and aftermarket support as essential elements of device value. In parallel, manufacturers have sought to absorb some cost burdens through process improvements, lean manufacturing, and design choices that reduce reliance on tariff-impacted inputs.

Finally, regulatory and contracting teams have become more vigilant in modeling supplier continuity and in requiring transparent disclosure of sourcing footprints. For stakeholders, the tariff landscape underscores the importance of scenario planning, diversified supplier networks, and contract clauses that address cost pass-through to maintain predictable access to endobronchial ultrasound biopsy devices and related consumables.

In-depth segmentation perspective illuminating how product types, offerings, end users, applications, and clinical indications uniquely influence device selection and adoption

Segmentation analysis reveals distinct performance drivers and adoption pathways when the market is examined through product type, product offering, end user, application, and clinical indication lenses. By product type, the field differentiates devices that utilize linear probes, which afford direct visualization for guided needle aspiration of mediastinal and hilar nodes, and radial probes, which excel at peripheral lesion localization and enable complementary diagnostic strategies. When viewed by product offering, equipment investments-such as imaging workstations and scope systems-anchor capital planning and integration costs, while consumables, including needle sets and protective sheaths, shape recurrent spending and procedural throughput.

End-user contexts further nuance adoption dynamics: ambulatory surgical centers prioritize compact, efficient systems and streamlined consumables to support high-throughput outpatient procedures; hospitals emphasize advanced imaging capabilities, broad device interoperability, and comprehensive service agreements; and specialty clinics seek cost-effective configurations that balance diagnostic performance with space and staffing constraints. Applications span mediastinal staging, which demands high precision and reproducibility for staging decisions; peripheral lesion diagnosis, where lesion accessibility and imaging resolution are decisive; and transbronchial needle aspiration, which combines imaging and tissue acquisition and stresses needle design and sampling ergonomics.

Finally, clinical indications-ranging from cancer diagnostics to infectious disease evaluation and sarcoidosis assessment-influence both device selection and procedural protocols, as tissue adequacy, sample handling, and downstream molecular testing requirements vary substantially across these diagnostic pathways.

Regional adoption patterns and commercial imperatives across the Americas, Europe, Middle East & Africa, and Asia-Pacific that shape deployment, training, and aftermarket strategies

Regional dynamics exert a pronounced influence on adoption patterns, regulatory expectations, and commercial strategies across the Americas, Europe, Middle East & Africa, and Asia-Pacific. In the Americas, a concentration of advanced tertiary care centers and robust interventional pulmonology programs supports early adoption of integrated imaging workstations and advanced scope systems, while payers increasingly scrutinize procedural pathways for cost-effectiveness and outcome alignment. Transitioning procedures to ambulatory surgical settings is creating new procurement priorities centered on mobility, ease of use, and consumable lifecycle management.

Within Europe, Middle East & Africa, heterogeneous regulatory environments and variable hospital funding models drive a mixture of centralized hospital deployments and targeted specialty clinic adoption. Manufacturers often tailor their market entry strategies to national reimbursement frameworks and to regional training partnerships with clinical societies. The Asia-Pacific region demonstrates accelerated uptake in urban tertiary centers and an expanding installed base driven by investments in cancer diagnostics infrastructure, with localized manufacturing and regional distribution partnerships playing pivotal roles in cost control and service responsiveness.

Across these regions, common themes emerge: emphasis on clinician training, the importance of service and warranty ecosystems, and the strategic role of consumables management in sustaining procedural volume. Decision-makers should therefore evaluate regional regulatory pathways, reimbursement nuances, and local clinical practice patterns when planning market entry or expansion.

Competitive landscape analysis highlighting divergent strategic models from integrated platform providers to consumable specialists and the implications for procurement and clinical adoption

Key companies within the endobronchial ultrasound biopsy ecosystem demonstrate a range of strategic approaches, from platform-integrated offerings to consumable-focused business models. Established endoscope manufacturers have leaned into system-level differentiation, combining high-resolution imaging workstations with modular scope architectures to capture procedural ecosystems and to drive consumable attachment. These firms emphasize long-term service contracts, clinician training programs, and bundled solutions that facilitate hospital integration and simplify procurement conversations.

Simultaneously, specialized manufacturers of needle systems and protective sheaths prioritize engineering focused on sampling reliability, tissue integrity, and single-use convenience. Their commercial strategies center on clinical evidence that demonstrates improved diagnostic yield and reduced repeat procedure rates, supported by targeted educational initiatives for interventional pulmonologists and cytopathology teams. Newer entrants and niche innovators often focus on adjunct technologies-such as navigation aids, biopsy forceps, or AI-enabled image enhancement-seeking strategic partnerships with platform holders to accelerate clinical adoption.

Overall, competitive dynamics are shaped by a balance between integrated platforms that lock in recurring consumable revenue and specialist suppliers that win on clinical performance and cost-efficient single-use designs. For purchasers, this dynamic increases the importance of evaluating total contractual arrangements, service level agreements, and the long-term roadmap for interoperability and software support.

Practical and high-impact strategic actions for manufacturers and healthcare providers to enhance clinical adoption, supply chain resilience, and long-term device value

Industry leaders seeking to strengthen market position and support sustainable clinical adoption should pursue a set of actionable strategies that align innovation with operational realities. First, prioritize end-to-end integration between scope systems and imaging workstations to deliver seamless clinical workflows and to reduce clinician friction at the point of care. Embedding robust training curricula and simulation-based credentialing will accelerate proficiency and minimize variability in biopsy technique, thereby improving sample quality and clinician confidence.

Second, develop resilient supply chains by diversifying component sourcing and by investing in regional manufacturing or assembly capabilities where feasible to mitigate trade and tariff exposure. Third, align commercial models with clinical workflows by offering flexible procurement options that address capital constraints, such as subscription-based access to imaging workstations combined with predictable consumable pricing. Fourth, invest in post-market evidence generation that demonstrates the impact of devices on diagnostic yield, downstream treatment decision-making, and patient experience, thereby supporting reimbursement discussions and hospital formulary inclusion.

Finally, foster interoperability and open data architectures to enable integration with electronic health records and multidisciplinary care platforms. These steps collectively will help firms and health systems navigate evolving clinical expectations, regulatory scrutiny, and fiscal pressures while expanding access to advanced endobronchial ultrasound biopsy capabilities.

Robust mixed-methods research approach integrating expert interviews, clinical literature review, and triangulated data analysis to validate insights and limit bias

The research methodology underpinning this analysis combined rigorous primary and secondary research techniques to ensure analytic depth and validity. Primary data collection included structured interviews with interventional pulmonologists, biomedical engineers, procurement leaders, and hospital administrators to capture real-world experiences with device performance, training needs, and consumable logistics. These expert inputs informed assessments of clinical workflows, device ergonomics, and procedural bottlenecks.

Secondary research encompassed a review of peer-reviewed clinical publications, device labeling and regulatory filings, clinical society guidelines, and publicly available regulatory communications to corroborate safety and efficacy claims and to map technology trends. Data triangulation ensured that insights reflected convergent evidence across sources, and sensitivity analyses were applied where qualitative inputs varied among experts. Segment definitions and regional analyses were constructed to align with clinical practice patterns, reimbursement frameworks, and supply chain geographies.

Limitations of the methodology include evolving regulatory landscapes and the pace of technological innovation, both of which can alter device capabilities and adoption dynamics. To address this, the research team applied conservative interpretation of nascent technologies and prioritized peer-reviewed evidence where available. Ethical considerations included anonymizing interview participants and securing consent for the use of proprietary insights in aggregate analysis.

Synthesis of strategic takeaways emphasizing technological progress, supply chain adaptation, and coordinated clinical strategies to maximize diagnostic outcomes

In conclusion, endobronchial ultrasound biopsy devices occupy a strategic position at the intersection of diagnostic precision, procedural safety, and operational efficiency. Technological innovations in probe design, imaging workstations, and single-use consumables are improving diagnostic performance while reshaping how procedures are delivered across ambulatory surgical centers, hospitals, and specialty clinics. At the same time, external pressures such as tariff-induced supply chain adjustments and evolving reimbursement practices are prompting manufacturers and providers to rethink sourcing, pricing, and commercialization models.

Successful deployment requires a holistic view that considers device interoperability, clinician training, consumable lifecycle management, and post-market evidence generation. By aligning product development with real-world clinical workflows and by establishing resilient supply chains, stakeholders can accelerate adoption while managing total cost of ownership and regulatory expectations. Ultimately, the balance between integrated platforms and high-performance consumables will determine how institutions structure purchasing decisions and how clinicians deliver consistent, high-quality diagnostic outcomes.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Growing adoption of linear endobronchial ultrasound devices integrated with real-time imaging guidance for improved lymph node sampling accuracy
  • 5.2. Development of single-use disposable ultrasound probes aiming to reduce infection risk and lower sterilization costs in endobronchial biopsy procedures
  • 5.3. Advancements in needle design featuring variable gauge and adjustable stiffness for enhanced access to difficult airway lesions during EBUS biopsies
  • 5.4. Increasing use of artificial intelligence and machine learning algorithms for automated lymph node detection and malignancy prediction during EBUS procedures
  • 5.5. Expansion of hybrid operating rooms equipped with EBUS and endoscopic navigational bronchoscopy systems to streamline diagnosis and therapy workflows
  • 5.6. Collaboration between medical device manufacturers and software companies to develop cloud-based EBUS data management and tele-mentoring platforms
  • 5.7. Rising demand for minimally invasive EBUS-guided cryobiopsy techniques for the safe collection of larger tissue specimens in interstitial lung disease diagnosis

6. Cumulative Impact of United States Tariffs 2025

7. Cumulative Impact of Artificial Intelligence 2025

8. Endobronchial Ultrasound Biopsy Devices Market, by Product Type

  • 8.1. Linear Probe
  • 8.2. Radial Probe

9. Endobronchial Ultrasound Biopsy Devices Market, by Product Offering

  • 9.1. Consumables
    • 9.1.1. Needle Sets
    • 9.1.2. Protective Sheaths
  • 9.2. Equipment
    • 9.2.1. Imaging Workstations
    • 9.2.2. Scope Systems

10. Endobronchial Ultrasound Biopsy Devices Market, by End User

  • 10.1. Ambulatory Surgical Centers
  • 10.2. Hospitals
  • 10.3. Specialty Clinics

11. Endobronchial Ultrasound Biopsy Devices Market, by Application

  • 11.1. Mediastinal Staging
  • 11.2. Peripheral Lesion Diagnosis
  • 11.3. Transbronchial Needle Aspiration

12. Endobronchial Ultrasound Biopsy Devices Market, by Indication

  • 12.1. Cancer Diagnostics
  • 12.2. Infectious Diseases
  • 12.3. Sarcoidosis

13. Endobronchial Ultrasound Biopsy Devices Market, by Region

  • 13.1. Americas
    • 13.1.1. North America
    • 13.1.2. Latin America
  • 13.2. Europe, Middle East & Africa
    • 13.2.1. Europe
    • 13.2.2. Middle East
    • 13.2.3. Africa
  • 13.3. Asia-Pacific

14. Endobronchial Ultrasound Biopsy Devices Market, by Group

  • 14.1. ASEAN
  • 14.2. GCC
  • 14.3. European Union
  • 14.4. BRICS
  • 14.5. G7
  • 14.6. NATO

15. Endobronchial Ultrasound Biopsy Devices Market, by Country

  • 15.1. United States
  • 15.2. Canada
  • 15.3. Mexico
  • 15.4. Brazil
  • 15.5. United Kingdom
  • 15.6. Germany
  • 15.7. France
  • 15.8. Russia
  • 15.9. Italy
  • 15.10. Spain
  • 15.11. China
  • 15.12. India
  • 15.13. Japan
  • 15.14. Australia
  • 15.15. South Korea

16. Competitive Landscape

  • 16.1. Market Share Analysis, 2024
  • 16.2. FPNV Positioning Matrix, 2024
  • 16.3. Competitive Analysis
    • 16.3.1. Olympus Corporation
    • 16.3.2. Fujifilm Holdings Corporation
    • 16.3.3. HOYA Corporation
    • 16.3.4. Boston Scientific Corporation
    • 16.3.5. Medtronic plc
    • 16.3.6. Karl Storz SE & Co. KG

LIST OF FIGURES

  • FIGURE 1. GLOBAL ENDOBRONCHIAL ULTRASOUND BIOPSY DEVICES MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 2. GLOBAL ENDOBRONCHIAL ULTRASOUND BIOPSY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2024 VS 2032 (%)
  • FIGURE 3. GLOBAL ENDOBRONCHIAL ULTRASOUND BIOPSY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 4. GLOBAL ENDOBRONCHIAL ULTRASOUND BIOPSY DEVICES MARKET SIZE, BY PRODUCT OFFERING, 2024 VS 2032 (%)
  • FIGURE 5. GLOBAL ENDOBRONCHIAL ULTRASOUND BIOPSY DEVICES MARKET SIZE, BY PRODUCT OFFERING, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 6. GLOBAL ENDOBRONCHIAL ULTRASOUND BIOPSY DEVICES MARKET SIZE, BY END USER, 2024 VS 2032 (%)
  • FIGURE 7. GLOBAL ENDOBRONCHIAL ULTRASOUND BIOPSY DEVICES MARKET SIZE, BY END USER, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 8. GLOBAL ENDOBRONCHIAL ULTRASOUND BIOPSY DEVICES MARKET SIZE, BY APPLICATION, 2024 VS 2032 (%)
  • FIGURE 9. GLOBAL ENDOBRONCHIAL ULTRASOUND BIOPSY DEVICES MARKET SIZE, BY APPLICATION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 10. GLOBAL ENDOBRONCHIAL ULTRASOUND BIOPSY DEVICES MARKET SIZE, BY INDICATION, 2024 VS 2032 (%)
  • FIGURE 11. GLOBAL ENDOBRONCHIAL ULTRASOUND BIOPSY DEVICES MARKET SIZE, BY INDICATION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 12. GLOBAL ENDOBRONCHIAL ULTRASOUND BIOPSY DEVICES MARKET SIZE, BY REGION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 13. AMERICAS ENDOBRONCHIAL ULTRASOUND BIOPSY DEVICES MARKET SIZE, BY SUBREGION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 14. NORTH AMERICA ENDOBRONCHIAL ULTRASOUND BIOPSY DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 15. LATIN AMERICA ENDOBRONCHIAL ULTRASOUND BIOPSY DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 16. EUROPE, MIDDLE EAST & AFRICA ENDOBRONCHIAL ULTRASOUND BIOPSY DEVICES MARKET SIZE, BY SUBREGION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 17. EUROPE ENDOBRONCHIAL ULTRASOUND BIOPSY DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 18. MIDDLE EAST ENDOBRONCHIAL ULTRASOUND BIOPSY DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 19. AFRICA ENDOBRONCHIAL ULTRASOUND BIOPSY DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 20. ASIA-PACIFIC ENDOBRONCHIAL ULTRASOUND BIOPSY DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 21. GLOBAL ENDOBRONCHIAL ULTRASOUND BIOPSY DEVICES MARKET SIZE, BY GROUP, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 22. ASEAN ENDOBRONCHIAL ULTRASOUND BIOPSY DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 23. GCC ENDOBRONCHIAL ULTRASOUND BIOPSY DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 24. EUROPEAN UNION ENDOBRONCHIAL ULTRASOUND BIOPSY DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 25. BRICS ENDOBRONCHIAL ULTRASOUND BIOPSY DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 26. G7 ENDOBRONCHIAL ULTRASOUND BIOPSY DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 27. NATO ENDOBRONCHIAL ULTRASOUND BIOPSY DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 28. GLOBAL ENDOBRONCHIAL ULTRASOUND BIOPSY DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 29. ENDOBRONCHIAL ULTRASOUND BIOPSY DEVICES MARKET SHARE, BY KEY PLAYER, 2024
  • FIGURE 30. ENDOBRONCHIAL ULTRASOUND BIOPSY DEVICES MARKET, FPNV POSITIONING MATRIX, 2024

LIST OF TABLES

  • TABLE 1. ENDOBRONCHIAL ULTRASOUND BIOPSY DEVICES MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
  • TABLE 3. GLOBAL ENDOBRONCHIAL ULTRASOUND BIOPSY DEVICES MARKET SIZE, 2018-2024 (USD MILLION)
  • TABLE 4. GLOBAL ENDOBRONCHIAL ULTRASOUND BIOPSY DEVICES MARKET SIZE, 2025-2032 (USD MILLION)
  • TABLE 5. GLOBAL ENDOBRONCHIAL ULTRASOUND BIOPSY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 6. GLOBAL ENDOBRONCHIAL ULTRASOUND BIOPSY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 7. GLOBAL ENDOBRONCHIAL ULTRASOUND BIOPSY DEVICES MARKET SIZE, BY LINEAR PROBE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 8. GLOBAL ENDOBRONCHIAL ULTRASOUND BIOPSY DEVICES MARKET SIZE, BY LINEAR PROBE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 9. GLOBAL ENDOBRONCHIAL ULTRASOUND BIOPSY DEVICES MARKET SIZE, BY LINEAR PROBE, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 10. GLOBAL ENDOBRONCHIAL ULTRASOUND BIOPSY DEVICES MARKET SIZE, BY LINEAR PROBE, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 11. GLOBAL ENDOBRONCHIAL ULTRASOUND BIOPSY DEVICES MARKET SIZE, BY LINEAR PROBE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 12. GLOBAL ENDOBRONCHIAL ULTRASOUND BIOPSY DEVICES MARKET SIZE, BY LINEAR PROBE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 13. GLOBAL ENDOBRONCHIAL ULTRASOUND BIOPSY DEVICES MARKET SIZE, BY RADIAL PROBE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 14. GLOBAL ENDOBRONCHIAL ULTRASOUND BIOPSY DEVICES MARKET SIZE, BY RADIAL PROBE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 15. GLOBAL ENDOBRONCHIAL ULTRASOUND BIOPSY DEVICES MARKET SIZE, BY RADIAL PROBE, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 16. GLOBAL ENDOBRONCHIAL ULTRASOUND BIOPSY DEVICES MARKET SIZE, BY RADIAL PROBE, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 17. GLOBAL ENDOBRONCHIAL ULTRASOUND BIOPSY DEVICES MARKET SIZE, BY RADIAL PROBE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 18. GLOBAL ENDOBRONCHIAL ULTRASOUND BIOPSY DEVICES MARKET SIZE, BY RADIAL PROBE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 19. GLOBAL ENDOBRONCHIAL ULTRASOUND BIOPSY DEVICES MARKET SIZE, BY PRODUCT OFFERING, 2018-2024 (USD MILLION)
  • TABLE 20. GLOBAL ENDOBRONCHIAL ULTRASOUND BIOPSY DEVICES MARKET SIZE, BY PRODUCT OFFERING, 2025-2032 (USD MILLION)
  • TABLE 21. GLOBAL ENDOBRONCHIAL ULTRASOUND BIOPSY DEVICES MARKET SIZE, BY CONSUMABLES, 2018-2024 (USD MILLION)
  • TABLE 22. GLOBAL ENDOBRONCHIAL ULTRASOUND BIOPSY DEVICES MARKET SIZE, BY CONSUMABLES, 2025-2032 (USD MILLION)
  • TABLE 23. GLOBAL ENDOBRONCHIAL ULTRASOUND BIOPSY DEVICES MARKET SIZE, BY CONSUMABLES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 24. GLOBAL ENDOBRONCHIAL ULTRASOUND BIOPSY DEVICES MARKET SIZE, BY CONSUMABLES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 25. GLOBAL ENDOBRONCHIAL ULTRASOUND BIOPSY DEVICES MARKET SIZE, BY CONSUMABLES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 26. GLOBAL ENDOBRONCHIAL ULTRASOUND BIOPSY DEVICES MARKET SIZE, BY CONSUMABLES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 27. GLOBAL ENDOBRONCHIAL ULTRASOUND BIOPSY DEVICES MARKET SIZE, BY CONSUMABLES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 28. GLOBAL ENDOBRONCHIAL ULTRASOUND BIOPSY DEVICES MARKET SIZE, BY CONSUMABLES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 29. GLOBAL ENDOBRONCHIAL ULTRASOUND BIOPSY DEVICES MARKET SIZE, BY NEEDLE SETS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 30. GLOBAL ENDOBRONCHIAL ULTRASOUND BIOPSY DEVICES MARKET SIZE, BY NEEDLE SETS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 31. GLOBAL ENDOBRONCHIAL ULTRASOUND BIOPSY DEVICES MARKET SIZE, BY NEEDLE SETS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 32. GLOBAL ENDOBRONCHIAL ULTRASOUND BIOPSY DEVICES MARKET SIZE, BY NEEDLE SETS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 33. GLOBAL ENDOBRONCHIAL ULTRASOUND BIOPSY DEVICES MARKET SIZE, BY NEEDLE SETS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 34. GLOBAL ENDOBRONCHIAL ULTRASOUND BIOPSY DEVICES MARKET SIZE, BY NEEDLE SETS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 35. GLOBAL ENDOBRONCHIAL ULTRASOUND BIOPSY DEVICES MARKET SIZE, BY PROTECTIVE SHEATHS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 36. GLOBAL ENDOBRONCHIAL ULTRASOUND BIOPSY DEVICES MARKET SIZE, BY PROTECTIVE SHEATHS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 37. GLOBAL ENDOBRONCHIAL ULTRASOUND BIOPSY DEVICES MARKET SIZE, BY PROTECTIVE SHEATHS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 38. GLOBAL ENDOBRONCHIAL ULTRASOUND BIOPSY DEVICES MARKET SIZE, BY PROTECTIVE SHEATHS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 39. GLOBAL ENDOBRONCHIAL ULTRASOUND BIOPSY DEVICES MARKET SIZE, BY PROTECTIVE SHEATHS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 40. GLOBAL ENDOBRONCHIAL ULTRASOUND BIOPSY DEVICES MARKET SIZE, BY PROTECTIVE SHEATHS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 41. GLOBAL ENDOBRONCHIAL ULTRASOUND BIOPSY DEVICES MARKET SIZE, BY EQUIPMENT, 2018-2024 (USD MILLION)
  • TABLE 42. GLOBAL ENDOBRONCHIAL ULTRASOUND BIOPSY DEVICES MARKET SIZE, BY EQUIPMENT, 2025-2032 (USD MILLION)
  • TABLE 43. GLOBAL ENDOBRONCHIAL ULTRASOUND BIOPSY DEVICES MARKET SIZE, BY EQUIPMENT, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 44. GLOBAL ENDOBRONCHIAL ULTRASOUND BIOPSY DEVICES MARKET SIZE, BY EQUIPMENT, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 45. GLOBAL ENDOBRONCHIAL ULTRASOUND BIOPSY DEVICES MARKET SIZE, BY EQUIPMENT, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 46. GLOBAL ENDOBRONCHIAL ULTRASOUND BIOPSY DEVICES MARKET SIZE, BY EQUIPMENT, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 47. GLOBAL ENDOBRONCHIAL ULTRASOUND BIOPSY DEVICES MARKET SIZE, BY EQUIPMENT, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 48. GLOBAL ENDOBRONCHIAL ULTRASOUND BIOPSY DEVICES MARKET SIZE, BY EQUIPMENT, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 49. GLOBAL ENDOBRONCHIAL ULTRASOUND BIOPSY DEVICES MARKET SIZE, BY IMAGING WORKSTATIONS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 50. GLOBAL ENDOBRONCHIAL ULTRASOUND BIOPSY DEVICES MARKET SIZE, BY IMAGING WORKSTATIONS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 51. GLOBAL ENDOBRONCHIAL ULTRASOUND BIOPSY DEVICES MARKET SIZE, BY IMAGING WORKSTATIONS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 52. GLOBAL ENDOBRONCHIAL ULTRASOUND BIOPSY DEVICES MARKET SIZE, BY IMAGING WORKSTATIONS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 53. GLOBAL ENDOBRONCHIAL ULTRASOUND BIOPSY DEVICES MARKET SIZE, BY IMAGING WORKSTATIONS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 54. GLOBAL ENDOBRONCHIAL ULTRASOUND BIOPSY DEVICES MARKET SIZE, BY IMAGING WORKSTATIONS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 55. GLOBAL ENDOBRONCHIAL ULTRASOUND BIOPSY DEVICES MARKET SIZE, BY SCOPE SYSTEMS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 56. GLOBAL ENDOBRONCHIAL ULTRASOUND BIOPSY DEVICES MARKET SIZE, BY SCOPE SYSTEMS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 57. GLOBAL ENDOBRONCHIAL ULTRASOUND BIOPSY DEVICES MARKET SIZE, BY SCOPE SYSTEMS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 58. GLOBAL ENDOBRONCHIAL ULTRASOUND BIOPSY DEVICES MARKET SIZE, BY SCOPE SYSTEMS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 59. GLOBAL ENDOBRONCHIAL ULTRASOUND BIOPSY DEVICES MARKET SIZE, BY SCOPE SYSTEMS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 60. GLOBAL ENDOBRONCHIAL ULTRASOUND BIOPSY DEVICES MARKET SIZE, BY SCOPE SYSTEMS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 61. GLOBAL ENDOBRONCHIAL ULTRASOUND BIOPSY DEVICES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 62. GLOBAL ENDOBRONCHIAL ULTRASOUND BIOPSY DEVICES MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 63. GLOBAL ENDOBRONCHIAL ULTRASOUND BIOPSY DEVICES MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 64. GLOBAL ENDOBRONCHIAL ULTRASOUND BIOPSY DEVICES MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 65. GLOBAL ENDOBRONCHIAL ULTRASOUND BIOPSY DEVICES MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 66. GLOBAL ENDOBRONCHIAL ULTRASOUND BIOPSY DEVICES MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 67. GLOBAL ENDOBRONCHIAL ULTRASOUND BIOPSY DEVICES MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 68. GLOBAL ENDOBRONCHIAL ULTRASOUND BIOPSY DEVICES MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 69. GLOBAL ENDOBRONCHIAL ULTRASOUND BIOPSY DEVICES MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 70. GLOBAL ENDOBRONCHIAL ULTRASOUND BIOPSY DEVICES MARKET SIZE, BY HOSPITALS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 71. GLOBAL ENDOBRONCHIAL ULTRASOUND BIOPSY DEVICES MARKET SIZE, BY HOSPITALS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 72. GLOBAL ENDOBRONCHIAL ULTRASOUND BIOPSY DEVICES MARKET SIZE, BY HOSPITALS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 73. GLOBAL ENDOBRONCHIAL ULTRASOUND BIOPSY DEVICES MARKET SIZE, BY HOSPITALS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 74. GLOBAL ENDOBRONCHIAL ULTRASOUND BIOPSY DEVICES MARKET SIZE, BY HOSPITALS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 75. GLOBAL ENDOBRONCHIAL ULTRASOUND BIOPSY DEVICES MARKET SIZE, BY SPECIALTY CLINICS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 76. GLOBAL ENDOBRONCHIAL ULTRASOUND BIOPSY DEVICES MARKET SIZE, BY SPECIALTY CLINICS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 77. GLOBAL ENDOBRONCHIAL ULTRASOUND BIOPSY DEVICES MARKET SIZE, BY SPECIALTY CLINICS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 78. GLOBAL ENDOBRONCHIAL ULTRASOUND BIOPSY DEVICES MARKET SIZE, BY SPECIALTY CLINICS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 79. GLOBAL ENDOBRONCHIAL ULTRASOUND BIOPSY DEVICES MARKET SIZE, BY SPECIALTY CLINICS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 80. GLOBAL ENDOBRONCHIAL ULTRASOUND BIOPSY DEVICES MARKET SIZE, BY SPECIALTY CLINICS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 81. GLOBAL ENDOBRONCHIAL ULTRASOUND BIOPSY DEVICES MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 82. GLOBAL ENDOBRONCHIAL ULTRASOUND BIOPSY DEVICES MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 83. GLOBAL ENDOBRONCHIAL ULTRASOUND BIOPSY DEVICES MARKET SIZE, BY MEDIASTINAL STAGING, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 84. GLOBAL ENDOBRONCHIAL ULTRASOUND BIOPSY DEVICES MARKET SIZE, BY MEDIASTINAL STAGING, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 85. GLOBAL ENDOBRONCHIAL ULTRASOUND BIOPSY DEVICES MARKET SIZE, BY MEDIASTINAL STAGING, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 86. GLOBAL ENDOBRONCHIAL ULTRASOUND BIOPSY DEVICES MARKET SIZE, BY MEDIASTINAL STAGING, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 87. GLOBAL ENDOBRONCHIAL ULTRASOUND BIOPSY DEVICES MARKET SIZE, BY MEDIASTINAL STAGING, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 88. GLOBAL ENDOBRONCHIAL ULTRASOUND BIOPSY DEVICES MARKET SIZE, BY MEDIASTINAL STAGING, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 89. GLOBAL ENDOBRONCHIAL ULTRASOUND BIOPSY DEVICES MARKET SIZE, BY PERIPHERAL LESION DIAGNOSIS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 90. GLOBAL ENDOBRONCHIAL ULTRASOUND BIOPSY DEVICES MARKET SIZE, BY PERIPHERAL LESION DIAGNOSIS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 91. GLOBAL ENDOBRONCHIAL ULTRASOUND BIOPSY DEVICES MARKET SIZE, BY PERIPHERAL LESION DIAGNOSIS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 92. GLOBAL ENDOBRONCHIAL ULTRASOUND BIOPSY DEVICES MARKET SIZE, BY PERIPHERAL LESION DIAGNOSIS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 93. GLOBAL ENDOBRONCHIAL ULTRASOUND BIOPSY DEVICES MARKET SIZE, BY PERIPHERAL LESION DIAGNOSIS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 94. GLOBAL ENDOBRONCHIAL ULTRASOUND BIOPSY DEVICES MARKET SIZE, BY PERIPHERAL LESION DIAGNOSIS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 95. GLOBAL ENDOBRONCHIAL ULTRASOUND BIOPSY DEVICES MARKET SIZE, BY TRANSBRONCHIAL NEEDLE ASPIRATION, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 96. GLOBAL ENDOBRONCHIAL ULTRASOUND BIOPSY DEVICES MARKET SIZE, BY TRANSBRONCHIAL NEEDLE ASPIRATION, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 97. GLOBAL ENDOBRONCHIAL ULTRASOUND BIOPSY DEVICES MARKET SIZE, BY TRANSBRONCHIAL NEEDLE ASPIRATION, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 98. GLOBAL ENDOBRONCHIAL ULTRASOUND BIOPSY DEVICES MARKET SIZE, BY TRANSBRONCHIAL NEEDLE ASPIRATION, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 99. GLOBAL ENDOBRONCHIAL ULTRASOUND BIOPSY DEVICES MARKET SIZE, BY TRANSBRONCHIAL NEEDLE ASPIRATION, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 100. GLOBAL ENDOBRONCHIAL ULTRASOUND BIOPSY DEVICES MARKET SIZE, BY TRANSBRONCHIAL NEEDLE ASPIRATION, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 101. GLOBAL ENDOBRONCHIAL ULTRASOUND BIOPSY DEVICES MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
  • TABLE 102. GLOBAL ENDOBRONCHIAL ULTRASOUND BIOPSY DEVICES MARKET SIZE, BY INDICATION, 2025-2032 (USD MILLION)
  • TABLE 103. GLOBAL ENDOBRONCHIAL ULTRASOUND BIOPSY DEVICES MARKET SIZE, BY CANCER DIAGNOSTICS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 104. GLOBAL ENDOBRONCHIAL ULTRASOUND BIOPSY DEVICES MARKET SIZE, BY CANCER DIAGNOSTICS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 105. GLOBAL ENDOBRONCHIAL ULTRASOUND BIOPSY DEVICES MARKET SIZE, BY CANCER DIAGNOSTICS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 106. GLOBAL ENDOBRONCHIAL ULTRASOUND BIOPSY DEVICES MARKET SIZE, BY CANCER DIAGNOSTICS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 107. GLOBAL ENDOBRONCHIAL ULTRASOUND BIOPSY DEVICES MARKET SIZE, BY CANCER DIAGNOSTICS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 108. GLOBAL ENDOBRONCHIAL ULTRASOUND BIOPSY DEVICES MARKET SIZE, BY CANCER DIAGNOSTICS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 109. GLOBAL ENDOBRONCHIAL ULTRASOUND BIOPSY DEVICES MARKET SIZE, BY INFECTIOUS DISEASES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 110. GLOBAL ENDOBRONCHIAL ULTRASOUND BIOPSY DEVICES MARKET SIZE, BY INFECTIOUS DISEASES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 111. GLOBAL ENDOBRONCHIAL ULTRASOUND BIOPSY DEVICES MARKET SIZE, BY INFECTIOUS DISEASES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 112. GLOBAL ENDOBRONCHIAL ULTRASOUND BIOPSY DEVICES MARKET SIZE, BY INFECTIOUS DISEASES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 113. GLOBAL ENDOBRONCHIAL ULTRASOUND BIOPSY DEVICES MARKET SIZE, BY INFECTIOUS DISEASES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 114. GLOBAL ENDOBRONCHIAL ULTRASOUND BIOPSY DEVICES MARKET SIZE, BY INFECTIOUS DISEASES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 115. GLOBAL ENDOBRONCHIAL ULTRASOUND BIOPSY DEVICES MARKET SIZE, BY SARCOIDOSIS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 116. GLOBAL ENDOBRONCHIAL ULTRASOUND BIOPSY DEVICES MARKET SIZE, BY SARCOIDOSIS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 117. GLOBAL ENDOBRONCHIAL ULTRASOUND BIOPSY DEVICES MARKET SIZE, BY SARCOIDOSIS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 118. GLOBAL ENDOBRONCHIAL ULTRASOUND BIOPSY DEVICES MARKET SIZE, BY SARCOIDOSIS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 119. GLOBAL ENDOBRONCHIAL ULTRASOUND BIOPSY DEVICES MARKET SIZE, BY SARCOIDOSIS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 120. GLOBAL ENDOBRONCHIAL ULTRASOUND BIOPSY DEVICES MARKET SIZE, BY SARCOIDOSIS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 121. GLOBAL ENDOBRONCHIAL ULTRASOUND BIOPSY DEVICES MARKET SIZE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 122. GLOBAL ENDOBRONCHIAL ULTRASOUND BIOPSY DEVICES MARKET SIZE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 123. AMERICAS ENDOBRONCHIAL ULTRASOUND BIOPSY DEVICES MARKET SIZE, BY SUBREGION, 2018-2024 (USD MILLION)
  • TABLE 124. AMERICAS ENDOBRONCHIAL ULTRASOUND BIOPSY DEVICES MARKET SIZE, BY SUBREGION, 2025-2032 (USD MILLION)
  • TABLE 125. AMERICAS ENDOBRONCHIAL ULTRASOUND BIOPSY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 126. AMERICAS ENDOBRONCHIAL ULTRASOUND BIOPSY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 127. AMERICAS ENDOBRONCHIAL ULTRASOUND BIOPSY DEVICES MARKET SIZE, BY PRODUCT OFFERING, 2018-2024 (USD MILLION)
  • TABLE 128. AMERICAS ENDOBRONCHIAL ULTRASOUND BIOPSY DEVICES MARKET SIZE, BY PRODUCT OFFERING, 2025-2032 (USD MILLION)
  • TABLE 129. AMERICAS ENDOBRONCHIAL ULTRASOUND BIOPSY DEVICES MARKET SIZE, BY CONSUMABLES, 2018-2024 (USD MILLION)
  • TABLE 130. AMERICAS ENDOBRONCHIAL ULTRASOUND BIOPSY DEVICES MARKET SIZE, BY CONSUMABLES, 2025-2032 (USD MILLION)
  • TABLE 131. AMERICAS ENDOBRONCHIAL ULTRASOUND BIOPSY DEVICES MARKET SIZE, BY EQUIPMENT, 2018-2024 (USD MILLION)
  • TABLE 132. AMERICAS ENDOBRONCHIAL ULTRASOUND BIOPSY DEVICES MARKET SIZE, BY EQUIPMENT, 2025-2032 (USD MILLION)
  • TABLE 133. AMERICAS ENDOBRONCHIAL ULTRASOUND BIOPSY DEVICES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 134. AMERICAS ENDOBRONCHIAL ULTRASOUND BIOPSY DEVICES MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 135. AMERICAS ENDOBRONCHIAL ULTRASOUND BIOPSY DEVICES MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 136. AMERICAS ENDOBRONCHIAL ULTRASOUND BIOPSY DEVICES MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 137. AMERICAS ENDOBRONCHIAL ULTRASOUND BIOPSY DEVICES MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
  • TABLE 138. AMERICAS ENDOBRONCHIAL ULTRASOUND BIOPSY DEVICES MARKET SIZE, BY INDICATION, 2025-2032 (USD MILLION)
  • TABLE 139. NORTH AMERICA ENDOBRONCHIAL ULTRASOUND BIOPSY DEVICES MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 140. NORTH AMERICA ENDOBRONCHIAL ULTRASOUND BIOPSY DEVICES MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 141. NORTH AMERICA ENDOBRONCHIAL ULTRASOUND BIOPSY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 142. NORTH AMERICA ENDOBRONCHIAL ULTRASOUND BIOPSY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 143. NORTH AMERICA ENDOBRONCHIAL ULTRASOUND BIOPSY DEVICES MARKET SIZE, BY PRODUCT OFFERING, 2018-2024 (USD MILLION)
  • TABLE 144. NORTH AMERICA ENDOBRONCHIAL ULTRASOUND BIOPSY DEVICES MARKET SIZE, BY PRODUCT OFFERING, 2025-2032 (USD MILLION)
  • TABLE 145. NORTH AMERICA ENDOBRONCHIAL ULTRASOUND BIOPSY DEVICES MARKET SIZE, BY CONSUMABLES, 2018-2024 (USD MILLION)
  • TABLE 146. NORTH AMERICA ENDOBRONCHIAL ULTRASOUND BIOPSY DEVICES MARKET SIZE, BY CONSUMABLES, 2025-2032 (USD MILLION)
  • TABLE 147. NORTH AMERICA ENDOBRONCHIAL ULTRASOUND BIOPSY DEVICES MARKET SIZE, BY EQUIPMENT, 2018-2024 (USD MILLION)
  • TABLE 148. NORTH AMERICA ENDOBRONCHIAL ULTRASOUND BIOPSY DEVICES MARKET SIZE, BY EQUIPMENT, 2025-2032 (USD MILLION)
  • TABLE 149. NORTH AMERICA ENDOBRONCHIAL ULTRASOUND BIOPSY DEVICES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 150. NORTH AMERICA ENDOBRONCHIAL ULTRASOUND BIOPSY DEVICES MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 151. NORTH AMERICA ENDOBRONCHIAL ULTRASOUND BIOPSY DEVICES MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 152. NORTH AMERICA ENDOBRONCHIAL ULTRASOUND BIOPSY DEVICES MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 153. NORTH AMERICA ENDOBRONCHIAL ULTRASOUND BIOPSY DEVICES MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
  • TABLE 154. NORTH AMERICA ENDOBRONCHIAL ULTRASOUND BIOPSY DEVICES MARKET SIZE, BY INDICATION, 2025-2032 (USD MILLION)
  • TABLE 155. LATIN AMERICA ENDOBRONCHIAL ULTRASOUND BIOPSY DEVICES MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 156. LATIN AMERICA ENDOBRONCHIAL ULTRASOUND BIOPSY DEVICES MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 157. LATIN AMERICA ENDOBRONCHIAL ULTRASOUND BIOPSY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 158. LATIN AMERICA ENDOBRONCHIAL ULTRASOUND BIOPSY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 159. LATIN AMERICA ENDOBRONCHIAL ULTRASOUND BIOPSY DEVICES MARKET SIZE, BY PRODUCT OFFERING, 2018-2024 (USD MILLION)
  • TABLE 160. LATIN AMERICA ENDOBRONCHIAL ULTRASOUND BIOPSY DEVICES MARKET SIZE, BY PRODUCT OFFERING, 2025-2032 (USD MILLION)
  • TABLE 161. LATIN AMERICA ENDOBRONCHIAL ULTRASOUND BIOPSY DEVICES MARKET SIZE, BY CONSUMABLES, 2018-2024 (USD MILLION)
  • TABLE 162. LATIN AMERICA ENDOBRONCHIAL ULTRASOUND BIOPSY DEVICES MARKET SIZE, BY CONSUMABLES, 2025-2032 (USD MILLION)
  • TABLE 163. LATIN AMERICA ENDOBRONCHIAL ULTRASOUND BIOPSY DEVICES MARKET SIZE, BY EQUIPMENT, 2018-2024 (USD MILLION)
  • TABLE 164. LATIN AMERICA ENDOBRONCHIAL ULTRASOUND BIOPSY DEVICES MARKET SIZE, BY EQUIPMENT, 2025-2032 (USD MILLION)
  • TABLE 165. LATIN AMERICA ENDOBRONCHIAL ULTRASOUND BIOPSY DEVICES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 166. LATIN AMERICA ENDOBRONCHIAL ULTRASOUND BIOPSY DEVICES MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 167. LATIN AMERICA ENDOBRONCHIAL ULTRASOUND BIOPSY DEVICES MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 168. LATIN AMERICA ENDOBRONCHIAL ULTRASOUND BIOPSY DEVICES MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 169. LATIN AMERICA ENDOBRONCHIAL ULTRASOUND BIOPSY DEVICES MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
  • TABLE 170. LATIN AMERICA ENDOBRONCHIAL ULTRASOUND BIOPSY DEVICES MARKET SIZE, BY INDICATION, 2025-2032 (USD MILLION)
  • TABLE 171. EUROPE, MIDDLE EAST & AFRICA ENDOBRONCHIAL ULTRASOUND BIOPSY DEVICES MARKET SIZE, BY SUBREGION, 2018-2024 (USD MILLION)
  • TABLE 172. EUROPE, MIDDLE EAST & AFRICA ENDOBRONCHIAL ULTRASOUND BIOPSY DEVICES MARKET SIZE, BY SUBREGION, 2025-2032 (USD MILLION)
  • TABLE 173. EUROPE, MIDDLE EAST & AFRICA ENDOBRONCHIAL ULTRASOUND BIOPSY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 174. EUROPE, MIDDLE EAST & AFRICA ENDOBRONCHIAL ULTRASOUND BIOPSY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 175. EUROPE, MIDDLE EAST & AFRICA ENDOBRONCHIAL ULTRASOUND BIOPSY DEVICES MARKET SIZE, BY PRODUCT OFFERING, 2018-2024 (USD MILLION)
  • TABLE 176. EUROPE, MIDDLE EAST & AFRICA ENDOBRONCHIAL ULTRASOUND BIOPSY DEVICES MARKET SIZE, BY PRODUCT OFFERING, 2025-2032 (USD MILLION)
  • TABLE 177. EUROPE, MIDDLE EAST & AFRICA ENDOBRONCHIAL ULTRASOUND BIOPSY DEVICES MARKET SIZE, BY CONSUMABLES, 2018-2024 (USD MILLION)
  • TABLE 178. EUROPE, MIDDLE EAST & AFRICA ENDOBRONCHIAL ULTRASOUND BIOPSY DEVICES MARKET SIZE, BY CONSUMABLES, 2025-2032 (USD MILLION)
  • TABLE 179. EUROPE, MIDDLE EAST & AFRICA ENDOBRONCHIAL ULTRASOUND BIOPSY DEVICES MARKET SIZE, BY EQUIPMENT, 2018-2024 (USD MILLION)
  • TABLE 180. EUROPE, MIDDLE EAST & AFRICA ENDOBRONCHIAL ULTRASOUND BIOPSY DEVICES MARKET SIZE, BY EQUIPMENT, 2025-2032 (USD MILLION)
  • TABLE 181. EUROPE, MIDDLE EAST & AFRICA ENDOBRONCHIAL ULTRASOUND BIOPSY DEVICES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 182. EUROPE, MIDDLE EAST & AFRICA ENDOBRONCHIAL ULTRASOUND BIOPSY DEVICES MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 183. EUROPE, MIDDLE EAST & AFRICA ENDOBRONCHIAL ULTRASOUND BIOPSY DEVICES MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 184. EUROPE, MIDDLE EAST & AFRICA ENDOBRONCHIAL ULTRASOUND BIOPSY DEVICES MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 185. EUROPE, MIDDLE EAST & AFRICA ENDOBRONCHIAL ULTRASOUND BIOPSY DEVICES MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
  • TABLE 186. EUROPE, MIDDLE EAST & AFRICA ENDOBRONCHIAL ULTRASOUND BIOPSY DEVICES MARKET SIZE, BY INDICATION, 2025-2032 (USD MILLION)
  • TABLE 187. EUROPE ENDOBRONCHIAL ULTRASOUND BIOPSY DEVICES MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 188. EUROPE ENDOBRONCHIAL ULTRASOUND BIOPSY DEVICES MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 189. EUROPE ENDOBRONCHIAL ULTRASOUND BIOPSY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 190. EUROPE ENDOBRONCHIAL ULTRASOUND BIOPSY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 191. EUROPE ENDOBRONCHIAL ULTRASOUND BIOPSY DEVICES MARKET SIZE, BY PRODUCT OFFERING, 2018-2024 (USD MILLION)
  • TABLE 192. EUROPE ENDOBRONCHIAL ULTRASOUND BIOPSY DEVICES MARKET SIZE, BY PRODUCT OFFERING, 2025-2032 (USD MILLION)
  • TABLE 193. EUROPE ENDOBRONCHIAL ULTRASOUND BIOPSY DEVICES MARKET SIZE, BY CONSUMABLES, 2018-2024 (USD MILLION)
  • TABLE 194. EUROPE ENDOBRONCHIAL ULTRASOUND BIOPSY DEVICES MARKET SIZE, BY CONSUMABLES, 2025-2032 (USD MILLION)
  • TABLE 195. EUROPE ENDOBRONCHIAL ULTRASOUND BIOPSY DEVICES MARKET SIZE, BY EQUIPMENT, 2018-2024 (USD MILLION)
  • TABLE 196. EUROPE ENDOBRONCHIAL ULTRASOUND BIOPSY DEVICES MARKET SIZE, BY EQUIPMENT, 2025-2032 (USD MILLION)
  • TABLE 197. EUROPE ENDOBRONCHIAL ULTRASOUND BIOPSY DEVICES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 198. EUROPE ENDOBRONCHIAL ULTRASOUND BIOPSY DEVICES MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 199. EUROPE ENDOBRONCHIAL ULTRASOUND BIOPSY DEVICES MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 200. EUROPE ENDOBRONCHIAL ULTRASOUND BIOPSY DEVICES MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 201. EUROPE ENDOBRONCHIAL ULTRASOUND BIOPSY DEVICES MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
  • TABLE 202. EUROPE ENDOBRONCHIAL ULTRASOUND BIOPSY DEVICES MARKET SIZE, BY INDICATION, 2025-2032 (USD MILLION)
  • TABLE 203. MIDDLE EAST ENDOBRONCHIAL ULTRASOUND BIOPSY DEVICES MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 204. MIDDLE EAST ENDOBRONCHIAL ULTRASOUND BIOPSY DEVICES MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 205. MIDDLE EAST ENDOBRONCHIAL ULTRASOUND BIOPSY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 206. MIDDLE EAST ENDOBRONCHIAL ULTRASOUND BIOPSY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 207. MIDDLE EAST ENDOBRONCHIAL ULTRASOUND BIOPSY DEVICES MARKET SIZE, BY PRODUCT OFFERING, 2018-2024 (USD MILLION)
  • TABLE 208. MIDDLE EAST ENDOBRONCHIAL ULTRASOUND BIOPSY DEVICES MARKET SIZE, BY PRODUCT OFFERING, 2025-2032 (USD MILLION)
  • TABLE 209. MIDDLE EAST ENDOBRONCHIAL ULTRASOUND BIOPSY DEVICES MARKET SIZE, BY CONSUMABLES, 2018-2024 (USD MILLION)
  • TABLE 210. MIDDLE EAST ENDOBRONCHIAL ULTRASOUND BIOPSY DEVICES MARKET SIZE, BY CONSUMABLES, 2025-2032 (USD MILLION)
  • TABLE 211. MIDDLE EAST ENDOBRONCHIAL ULTRASOUND BIOPSY DEVICES MARKET SIZE, BY EQUIPMENT, 2018-2024 (USD MILLION)
  • TABLE 212. MIDDLE EAST ENDOBRONCHIAL ULTRASOUND BIOPSY DEVICES MARKET SIZE, BY EQUIPMENT, 2025-2032 (USD MILLION)
  • TABLE 213. MIDDLE EAST ENDOBRONCHIAL ULTRASOUND BIOPSY DEVICES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 214. MIDDLE EAST ENDOBRONCHIAL ULTRASOUND BIOPSY DEVICES MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 215. MIDDLE EAST ENDOBRONCHIAL ULTRASOUND BIOPSY DEVICES MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 216. MIDDLE EAST ENDOBRONCHIAL ULTRASOUND BIOPSY DEVICES MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 217. MIDDLE EAST ENDOBRONCHIAL ULTRASOUND BIOPSY DEVICES MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
  • TABLE 218. MIDDLE EAST ENDOBRONCHIAL ULTRASOUND BIOPSY DEVICES MARKET SIZE, BY INDICATION, 2025-2032 (USD MILLION)
  • TABLE 219. AFRICA ENDOBRONCHIAL ULTRASOUND BIOPSY DEVICES MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 220. AFRICA ENDOBRONCHIAL ULTRASOUND BIOPSY DEVICES MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 221. AFRICA ENDOBRONCHIAL ULTRASOUND BIOPSY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 222. AFRICA ENDOBRONCHIAL ULTRASOUND BIOPSY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 223. AFRICA ENDOBRONCHIAL ULTRASOUND BIOPSY DEVICES MARKET SIZE, BY PRODUCT OFFERING, 2018-2024 (USD MILLION)
  • TABLE 224. AFRICA ENDOBRONCHIAL ULTRASOUND BIOPSY DEVICES MARKET SIZE, BY PRODUCT OFFERING, 2025-2032 (USD MILLION)
  • TABLE 225. AFRICA ENDOBRONCHIAL ULTRASOUND BIOPSY DEVICES MARKET SIZE, BY CONSUMABLES, 2018-2024 (USD MILLION)
  • TABLE 226. AFRICA ENDOBRONCHIAL ULTRASOUND BIOPSY DEVICES MARKET SIZE, BY CONSUMABLES, 2025-2032 (USD MILLION)
  • TABLE 227. AFRICA ENDOBRONCHIAL ULTRASOUND BIOPSY DEVICES MARKET SIZE, BY EQUIPMENT, 2018-2024 (USD MILLION)
  • TABLE 228. AFRICA ENDOBRONCHIAL ULTRASOUND BIOPSY DEVICES MARKET SIZE, BY EQUIPMENT, 2025-2032 (USD MILLION)
  • TABLE 229. AFRICA ENDOBRONCHIAL ULTRASOUND BIOPSY DEVICES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 230. AFRICA ENDOBRONCHIAL ULTRASOUND BIOPSY DEVICES MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 231. AFRICA ENDOBRONCHIAL ULTRASOUND BIOPSY DEVICES MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 232. AFRICA ENDOBRONCHIAL ULTRASOUND BIOPSY DEVICES MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 233. AFRICA ENDOBRONCHIAL ULTRASOUND BIOPSY DEVICES MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
  • TABLE 234. AFRICA ENDOBRONCHIAL ULTRASOUND BIOPSY DEVICES MARKET SIZE, BY INDICATION, 2025-2032 (USD MILLION)
  • TABLE 235. ASIA-PACIFIC ENDOBRONCHIAL ULTRASOUND BIOPSY DEVICES MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 236. ASIA-PACIFIC ENDOBRONCHIAL ULTRASOUND BIOPSY DEVICES MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 237. ASIA-PACIFIC ENDOBRONCHIAL ULTRASOUND BIOPSY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 238. ASIA-PACIFIC ENDOBRONCHIAL ULTRASOUND BIOPSY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 239. ASIA-PACIFIC ENDOBRONCHIAL ULTRASOUND BIOPSY DEVICES MARKET SIZE, BY PRODUCT OFFERING, 2018-2024 (USD MILLION)
  • TABLE 240. ASIA-PACIFIC ENDOBRONCHIAL ULTRASOUND BIOPSY DEVICES MARKET SIZE, BY PRODUCT OFFERING, 2025-2032 (USD MILLION)
  • TABLE 241. ASIA-PACIFIC ENDOBRONCHIAL ULTRASOUND BIOPSY DEVICES MARKET SIZE, BY CONSUMABLES, 2018-2024 (USD MILLION)
  • TABLE 242. ASIA-PACIFIC ENDOBRONCHIAL ULTRASOUND BIOPSY DEVICES MARKET SIZE, BY CONSUMABLES, 2025-2032 (USD MILLION)
  • TABLE 243. ASIA-PACIFIC ENDOBRONCHIAL ULTRASOUND BIOPSY DEVICES MARKET SIZE, BY EQUIPMENT, 2018-2024 (USD MILLION)
  • TABLE 244. ASIA-PACIFIC ENDOBRONCHIAL ULTRASOUND BIOPSY DEVICES MARKET SIZE, BY EQUIPMENT, 2025-2032 (USD MILLION)
  • TABLE 245. ASIA-PACIFIC ENDOBRONCHIAL ULTRASOUND BIOPSY DEVICES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 246. ASIA-PACIFIC ENDOBRONCHIAL ULTRASOUND BIOPSY DEVICES MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 247. ASIA-PACIFIC ENDOBRONCHIAL ULTRASOUND BIOPSY DEVICES MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 248. ASIA-PACIFIC ENDOBRONCHIAL ULTRASOUND BIOPSY DEVICES MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 249. ASIA-PACIFIC ENDOBRONCHIAL ULTRASOUND BIOPSY DEVICES MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
  • TABLE 250. ASIA-PACIFIC ENDOBRONCHIAL ULTRASOUND BIOPSY DEVICES MARKET SIZE, BY INDICATION, 2025-2032 (USD MILLION)
  • TABLE 251. GLOBAL ENDOBRONCHIAL ULTRASOUND BIOPSY DEVICES MARKET SIZE, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 252. GLOBAL ENDOBRONCHIAL ULTRASOUND BIOPSY DEVICES MARKET SIZE, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 253. ASEAN ENDOBRONCHIAL ULTRASOUND BIOPSY DEVICES MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 254. ASEAN ENDOBRONCHIAL ULTRASOUND BIOPSY DEVICES MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 255. ASEAN ENDOBRONCHIAL ULTRASOUND BIOPSY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 256. ASEAN ENDOBRONCHIAL ULTRASOUND BIOPSY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 257. ASEAN ENDOBRONCHIAL ULTRASOUND BIOPSY DEVICES MARKET SIZE, BY PRODUCT OFFERING, 2018-2024 (USD MILLION)
  • TABLE 258. ASEAN ENDOBRONCHIAL ULTRASOUND BIOPSY DEVICES MARKET SIZE, BY PRODUCT OFFERING, 2025-2032 (USD MILLION)
  • TABLE 259. ASEAN ENDOBRONCHIAL ULTRASOUND BIOPSY DEVICES MARKET SIZE, BY CONSUMABLES, 2018-2024 (USD MILLION)
  • TABLE 260. ASEAN ENDOBRONCHIAL ULTRASOUND BIOPSY DEVICES MARKET SIZE, BY CONSUMABLES, 2025-2032 (USD MILLION)
  • TABLE 261. ASEAN ENDOBRONCHIAL ULTRASOUND BIOPSY DEVICES MARKET SIZE, BY EQUIPMENT, 2018-2024 (USD MILLION)
  • TABLE 262. ASEAN ENDOBRONCHIAL ULTRASOUND BIOPSY DEVICES MARKET SIZE, BY EQUIPMENT, 2025-2032 (USD MILLION)
  • TABLE 263. ASEAN ENDOBRONCHIAL ULTRASOUND BIOPSY DEVICES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 264. ASEAN ENDOBRONCHIAL ULTRASOUND BIOPSY DEVICES MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 265. ASEAN ENDOBRONCHIAL ULTRASOUND BIOPSY DEVICES MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 266. ASEAN ENDOBRONCHIAL ULTRASOUND BIOPSY DEVICES MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 267. ASEAN ENDOBRONCHIAL ULTRASOUND BIOPSY DEVICES MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
  • TABLE 268. ASEAN ENDOBRONCHIAL ULTRASOUND BIOPSY DEVICES MARKET SIZE, BY INDICATION, 2025-2032 (USD MILLION)
  • TABLE 269. GCC ENDOBRONCHIAL ULTRASOUND BIOPSY DEVICES MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 270. GCC ENDOBRONCHIAL ULTRASOUND BIOPSY DEVICES MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 271. GCC ENDOBRONCHIAL ULTRASOUND BIOPSY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 272. GCC ENDOBRONCHIAL ULTRASOUND BIOPSY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 273. GCC ENDOBRONCHIAL ULTRASOUND BIOPSY DEVICES MARKET SIZE, BY PRODUCT OFFERING, 2018-2024 (USD MILLION)
  • TABLE 274. GCC ENDOBRONCHIAL ULTRASOUND BIOPSY DEVICES MARKET SIZE, BY PRODUCT OFFERING, 2025-2032 (USD MILLION)
  • TABLE 275. GCC ENDOBRONCHIAL ULTRASOUND BIOPSY DEVICES MARKET SIZE, BY CONSUMABLES, 2018-2024 (USD MILLION)
  • TABLE 276. GCC ENDOBRONCHIAL ULTRASOUND BIOPSY DEVICES MARKET SIZE, BY CONSUMABLES, 2025